Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia.
Rizzieri DA, Bass AJ, Rosner GL, Gockerman JP, DeCastro CM, Petros WP, Adams DJ, Laughlin MJ, Davis P, Foster T, Jacobson R, Hurwitz H, Moore JO.
Rizzieri DA, et al. Among authors: decastro cm.
J Clin Oncol. 2002 Feb 1;20(3):674-9. doi: 10.1200/JCO.2002.20.3.674.
J Clin Oncol. 2002.
PMID: 11821447
Clinical Trial.